Health Canada
- Status: approved
Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
University of California, San Diego is the originator. The local marketing authorisation holder may differ — check the official source linked above.